AXAxinet
Menu
Finance

Live market screen

Commercial Space Company Risk / Opportunity Ranking

Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.

Updated June 27, 2026

Companies analyzed
438
Ranked rows
876
Evidence links
356
Rows per page
20

Opportunity view

Showing rows 201-220 of 438; 20 rows per page.

Sorted by raw opportunity score
RankCompanyScoreThesis / Evidence
201
Kurs Orbital
lowweak
Opp 2
Risk 1

Thesis: There is limited relevance support that Kurs Orbital is an operating in-orbit servicing company, which could fit a long-horizon commercial space opportunity framework, but the evidence is only undated directory-style article context rather than direct company-specific positive events or facts.

Why now: The only retained evidence is an undated external sector index listing Kurs Orbital as operating in in-orbit servicing, so timing and recency are uncertain.

Evidence
  • Space Index lists Kurs Orbital, HQ Turin, Italy, status 'operating' within 'In-Orbit Servicing & Assembly Companies.' This is undated supporting article context, not a dated company-specific event. spaceindex.io

Caveats: Evidence is undated and the reviewed sources explicitly says undated external evidence is relevance context, not recency proof. Same-article repeated rows are not independent confirmation. No financing, contract, revenue, product milestone, or regulatory evidence is provided.

202
Leidos Holdings, Inc.
lowweak
Opp 2
Risk 1

Thesis: The reviewed sources rationale says Leidos delivered a cloud-based Joint Management Tool to DISA for SATCOM visibility and modernization, suggesting a role in defense SATCOM infrastructure, but no within the recent evidence window evidence are available to support a stronger long-horizon opportunity thesis.

Why now: No surviving evidence are available after the 90-day filter despite 300 articles considered. The rationale cites: and: but no are provided in these reviewed sources.

Caveats: Membership rationale is not direct directional proof. No retained evidence after recent evidence window. Cohort fit is ambiguous because support is infrastructure/IT modernization rather than operator economics.

203
LeoLabs, Inc.
lowweak
Opp 2
Risk 1

Thesis: LeoLabs is described in membership rationale as deploying radar for space domain awareness with Space Force/SpaceWERX support, which is strategically relevant, but no available direct evidence support a stronger opportunity call.

Why now: No dated company-specific evidence are available after filtering, so there is no strong timing signal in these reviewed sources.

Caveats: No usable evidence after recent evidence window. Membership rationale is insufficient for a high score.

204
Leonardo S.p.A.
lowweak
Opp 2
Risk 1

Thesis: Older context suggests strategic optionality from self-funding an Earth-observation constellation of 20 radar and IR imagers, but this evidence is outside the 90-day recent evidence window and therefore insufficient for a strong current ranking.

Why now: The only concrete company-specific article summary says Leonardo was self-funding a 20-satellite Earth-observation constellation on February 23, 2026, but that date is older than the March 29, 2026 cutoff, so recency is insufficient for a stronger current thesis.

Evidence
  • February 23, 2026: Leonardo is self-funding development of an Earth observation constellation consisting of 20 radar and IR imagers. This is strategically positive context but outside the 90-day recent evidence window cutoff. spacetimespod.substack.com

Caveats: The cited article is outside the 90-day recent evidence window; reviewed sources reports kept_rows 0 and dropped_rows 2. No retained positive or negative evidence exist after filtering. Article-level recap context is weaker than direct event/fact evidence.

205
Lockheed Martin Corporation
lowweak
Opp 2
Risk 2

Thesis: The reviewed sources membership rationale references space and defense satellite activity that could support long-term opportunity, but no usable recent evidence window-valid evidence are available here.

Why now: There is no available why-now evidence within the 90-day recent evidence window; coverage data shows zero evidence after recent evidence window.

Caveats: Phase2 rationale cites, and, but no representative articles or evidence are available in the reviewed sources body for citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low score reflects insufficient current reviewed sources evidence, not a negative fundamental view.

206
Lux Aeterna
lowweak
Opp 2
Risk 2

Thesis: The membership rationale says Lux Aeterna completed a $10 million seed financing and is building a fully reusable satellite platform, which is directionally positive, but the reviewed sources contain no retained within the recent evidence window article evidence or to support a stronger thesis.

Why now: No within the recent evidence window evidence were retained for ranking, so there is no evidence-backed near-term or durable timing edge beyond generic early-stage company progress assumptions.

Caveats: Membership rationale references article: but the reviewed sources does not include its or a retained evidence row.

207
Lynk Global, Inc.
lowweak
Opp 2
Risk 2

Thesis: The reviewed sources say Lynk Global was listed as a payload on a Falcon 9 rideshare mission, which hints at tangible space activity and gives slightly more concrete relevance than pure market-list context, but it still does not establish a supported long-horizon opportunity thesis without direct evidence or.

Why now: If a rideshare payload mention reflects program progress, that could matter over 1 year+, but the reviewed sources provide no citable event details, timestamps, quote, or for article ids: and

Caveats: A payload mention is more concrete than generic context, but still insufficient here because no direct evidence row or citation is included. No recent evidence window-surviving evidence exists in the reviewed sources. Slight score uplift reflects somewhat more operationally concrete context only.

208
MBRYONICS Ltd
lowweak
Opp 2
Risk 2

Thesis: There is weak potential opportunity from the reviewed sources' membership rationale that MBRYONICS was a partner on an ESA optical communications project, but the ranking reviewed sources contain no kept direct evidence or citable for that claim.

Why now: Why now is weak because only a membership rationale references article about participation in an ESA optical communications project led by Kepler Communications, but no article or reviewed evidence is available for ranking citation.

Caveats: Relation-style partnership context cannot be overused as directional proof. No article is provided for article. Coverage after recent evidence window is empty.

209
Mercury Systems Inc
lowweak
Opp 2
Risk 1

Thesis: The reviewed sources rationale says Mercury supplies solid-state data recorders for SDA tracking satellites, which supports space-program exposure, but there are no retained within the recent evidence window evidence to confirm timing, scale, or durability.

Why now: There is no surviving 90-day evidence to establish a current catalyst. The rationale references and: without in these reviewed sources.

Caveats: Supplier exposure alone is not enough for a strong positive thesis without direct, timely event evidence. No retained evidence after recent evidence window.

210
Meridian Space
lowweak
Opp 2
Risk 1

Thesis: The reviewed sources rationale says Meridian Space is a broadband constellation for which 280 satellites are being built, which suggests strategic scale potential, but the actual article evidence is not surfaced in the reviewed sources fields used for ranking, so opportunity support is limited.

Why now: Why now is weak because there are no representative articles or available evidence after recent evidence window, and the only support is the membership rationale referencing: without article summary details in the ranking fields.

Caveats: No representative article content is included for direct citation beyond membership rationale reference. No direct positive or negative evidence are available after recent evidence window. Scoring is constrained by sparse surfaced evidence.

211
Motiv Space Systems
lowweak
Opp 2
Risk 2

Thesis: Only a weak opportunity case is supported: undated external article-context lists Motiv Space Systems as an operating in-orbit servicing and assembly company, which suggests continued relevance to the sector but does not prove current growth, contracts, or milestones.

Why now: Why now is weak because the only provided evidence is undated context from Space Index identifying Motiv as operating in in-orbit servicing; no recent dated milestone or contract is supplied.

Evidence
  • Undated Space Index context lists Motiv Space Systems in Pasadena, California as an operating in-orbit servicing and assembly company. spaceindex.io

Caveats: Evidence is undated and supporting article context only. Reviewed evidence membership rationale mentions acquisition by Rocket Lab and robotics products, but no citable evidence are included here for direct ranking use. No current source-cited catalyst was found in the reviewed sources.

212
Mynaric AG
lowweak
Opp 2
Risk 2

Thesis: Membership rationale describes Mynaric as a laser optical communications terminal provider acquired by Rocket Lab, which implies strategic relevance to space communications hardware, but no direct evidence within the recent evidence window are available to support a durable opportunity call.

Why now: No within the recent evidence window retained evidence exists. The reviewed sources references and in the membership rationale, but no or retained evidence are provided here.

Caveats: No available direct evidence survived the 90-day recent evidence window. Acquisition/status claim appears only in membership rationale here and cannot be fully evaluated for timing without or timestamps.

213
Mynaric AG
lowweak
Opp 2
Risk 2

Thesis: The reviewed sources rationale says Mynaric is an acquired laser optical communications company, indicating potentially strategic technology relevance, but there is no direct positive evidence row, quote, or to support a durable opportunity thesis.

Why now: Potential relevance depends on the timing and implications of acquisition-related developments, yet the reviewed sources supplies no article summary, or surviving evidence row for article ids, or

Caveats: Acquisition-related statements are time-sensitive, but chronology cannot be verified from these reviewed sources because and timestamps are absent at the evidence level. No evidence remain after recent evidence window despite support references being listed. Slight score uplift reflects reviewed sources rationale about optical communications relevance only.

214
N SPACE TECH
lowweak
Opp 2
Risk 2

Thesis: N SPACE TECH has thematic relevance because the membership rationale profiles it as an Indian aerospace/defense startup designing CubeSats, RF subsystems, radars, and antennas and working with ISRO and DRDO, but the reviewed sources contain no retained 90-day evidence to convert that profile into a current opportunity thesis.

Why now: There is no retained within the recent evidence window evidence in the reviewed sources, so there is no demonstrated current catalyst despite the company profile reference.

Caveats: Only a membership rationale is present; no recent evidence are retained. Score remains low due to evidence scarcity.

215
Nanoracks
lowweak
Opp 2
Risk 1

Thesis: The reviewed sources includes one external article summary saying NASA awarded Nanoracks a $160 million contract to develop a commercial space station, which is strategically positive if still relevant, but the article is dated September 2, 2025 and was dropped by the 90-day recent evidence window, so support for a current 1 year+ opportunity ranking is weak.

Why now: There is no valid within the recent evidence window catalyst. The only company-specific article is at with September 2, 2025, and the reviewed sources say it was excluded by the 90-day cutoff.

Evidence
  • External article summary states NASA awarded Nanoracks a $160 million contract to develop a commercial space station to help replace the ISS; is September 2, 2025, but the reviewed sources' recent evidence review says the row was dropped as outside the 90-day window. scimyst.com

Caveats: The only cited article is outside the selected 90-day evidence recent evidence window and therefore should not drive strong ranking. This is supporting source context, not merged serving evidence. No retained direct positive or negative evidence remain after recent evidence window.

216
NordSpace
lowweak
Opp 2
Risk 4

Thesis: Reviewed evidence membership rationale says NordSpace is a private Canadian aerospace/defence startup awarded defense funding for a VLEO satellite concept and planning launches from its own spaceport complex, which would be strategically relevant if current, but no direct evidence or article summaries survived the available recent evidence window in these reviewed sources, so opportunity cannot be ranked highly on evidence alone, unavailable in reviewed sources).

Why now: Why now is weak because coverage data shows zero articles after recent evidence window and zero evidence after the 90-day filter, so there is no current catalyst evidence to support a 1 year+ differentiated view from these reviewed sources.

Caveats: No article is provided for the membership-support. No direct positive or negative evidence were available after recent evidence window. Private-company status reduces external validation in these reviewed sources.

217
NorthStar Earth & Space Inc.
lowweak
Opp 2
Risk 4

Thesis: There is not enough in-window evidence in this specific row to support a strong positive thesis beyond generic cohort relevance.

Why now: Why-now is weak because the evidence recent evidence review shows zero kept rows after the 90-day cutoff and the row contains no representative articles or direct evidence, so recency and business state are uncertain in these reviewed sources.

Caveats: No evidence were available after the recent evidence window for this row. Any statement about public listing, SPAC timing, or operations would be insufficiently grounded from this row alone. Score is driven by evidence absence, not by documented adverse developments.

218
OHB SE
lowweak
Opp 2
Risk 2

Thesis: OHB may have long-horizon opportunity through satellite manufacturing and in-orbit testing infrastructure exposure, as the membership rationale says Mimir 1 was built by OHB Sweden, but there is no retained 90-day evidence in the reviewed sources to support a current ranking catalyst.

Why now: There is no within the recent evidence window retained evidence to establish a fresh catalyst or changing business state.

Caveats: Only membership rationale is available; no quoted retained evidence are included. Low score reflects weak current evidence rather than a negative fundamental view.

219
Optera
lowweak
Opp 2
Risk 2

Thesis: Phase-2 rationale says Optera received UK space-sector early-stage funding and additional private capital, which could be positive if confirmed, but the current reviewed sources retains no in-window evidence to support a stronger ranking.

Why now: There is no retained representative article or evidence row inside the current 90-day recent evidence window for Optera, so recency for the claimed funding support is uncertain in these reviewed sources.

Caveats: No retained evidence after recent evidence window. Phase-2 membership rationale is not enough for a high-conviction thesis on its own.

220
Paladin Space
lowweak
Opp 2
Risk 2

Thesis: Reviewed evidence membership rationale says Paladin Space is partnering to offer debris removal as a service using its Triton payload, which suggests exposure to on-orbit servicing and sustainability themes over a long horizon, but no citeable direct evidence are provided.

Why now: Why now is weak since the reviewed sources contain no direct post-recent evidence window evidence establishing current deal timing or mission progress.

Caveats: One-article universe with no citeable -bearing evidence available. Partnership mention in membership rationale cannot be strongly weighted without direct evidence.

Risk view

Showing rows 281-300 of 438; 20 rows per page.

Sorted by raw risk score
RankCompanyScoreThesis / Evidence
281
COMSAT
lowweak
Opp 0
Risk 1

Thesis: No material adverse thesis is supported either. The reviewed sources only provides thin acquisition-context mention, so risk remains low-scored for lack of evidence rather than comfort.

Why now: No 90-day article summaries or evidence were available for COMSAT in these reviewed sources, so there is no supported timing catalyst.

Caveats: Relations/context-only style mention should not be used as counterparty propagation evidence. Phase2 rationale references article ids: and: but no or summaries are provided in the reviewed sources. No direct evidence were available after recent evidence window.

282
Comtech Telecommunications Corp.
lowweak
Opp 1
Risk 1

Thesis: No material adverse thesis can be supported from these reviewed sources because no direct negative evidence are provided within the recent evidence window.

Why now: There is no usable company-specific evidence in the reviewed sources after recent evidence filtering; coverage data shows zero article IDs after recent evidence window and zero evidence available, so there is no current catalyst basis in these reviewed sources.

Caveats: Absence of evidence is not positive evidence. Reviewed evidence notes only weak peer-group context in phase2 rationale, but no citable article details are included in the scoring fields.

283
Cosmoserve
lowweak
Opp 1
Risk 1

Thesis: No material adverse company-specific evidence is provided. The primary risk is simply that the evidence is too indirect to support a real thesis.

Why now: No in-recent evidence window article summary or evidence row was available for Cosmoserve, so there is no supported catalyst timing.

Caveats: The mention is article-level and indirect rather than company-specific. Phase2 rationale references article id: but no or summary is included. No direct evidence were available after recent evidence window.

284
Cosmoserve Space
lowweak
Opp 1
Risk 1

Thesis: No retained 90-day negative evidence supports a risk thesis.

Why now: The reviewed sources retains zero evidence after the recent evidence filter, leaving no current catalyst or recency-supported business update.

Caveats: Only one historical article was considered and none are retained within the recent evidence window. The single membership support item is not enough for a current directional call. This is effectively a watchlist placeholder until newer evidence appears.

285
Curtiss-Wright Corporation
lowweak
Opp 2
Risk 1

Thesis: No material adverse evidence is available. The main risk is evidentiary weakness: supplier-beneficiary framing without direct contract, backlog, or financial evidence leaves the thesis unproven.

Why now: Potentially relevant if broader space spending is increasing, but the reviewed sources provide no retained dated evidence, no current data, so timing and magnitude cannot be validated.

Caveats: No current evidence is provided for Relation/context evidence must not be used as counterparty propagation; reviewed sources notes context only. No available direct evidence after recent evidence window despite high article count considered.

286
Deloitte
lowweak
Opp 2
Risk 1

Thesis: No material negative evidence is retained in the reviewed sources.

Why now: The reviewed sources rationale says Deloitte launched satellites for Project Constellation to test on-orbit cyber protections and contracted Spire to design, build, and operate satellites, citing article, but no or retained evidence row is available after recent evidence window, limiting confidence.

Caveats: The described activity comes only from membership rationale rather than retained evidence. Without retained dated evidence or, chronology and durability cannot be tested.

287
Digantara
lowweak
Opp 1
Risk 1

Thesis: No retained 90-day negative evidence supports a material risk call.

Why now: Despite several historical mentions, the reviewed sources show zero retained article IDs and zero evidence after recent evidence filtering, so there is no recent catalyst evidence in the served data.

Caveats: Historical support mentions approximately $50M funding, but the underlying evidence is not retained within the current recent evidence window reviewed sources. Low scores reflect missing current evidence, not a negative operating judgment.

288
Digantara
lowweak
Opp 1
Risk 1

Thesis: No direct adverse evidence is provided in the reviewed sources. The main issue is lack of current evidence within the recent evidence window, so risk cannot be ranked highly.

Why now: There is no strong 'why now' because coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so any thesis would be under-supported for current timing.

Caveats: No evidence remained after the 90-day recent evidence window. Phase-2 membership rationale is not enough for a directional thesis by itself. Recency and business-state claims are unavailable in the reviewed sources.

289
DPhi Space
lowweak
Opp 1
Risk 1

Thesis: No material adverse thesis is supported. The main issue is lack of substantiated company-specific evidence.

Why now: No available article summaries or evidence exist after recent evidence window for DPhi Space in these reviewed sources, so there is no supported why-now catalyst.

Caveats: Support level is only provisional_single_article_context in the reviewed sources. Phase2 rationale references article id, but no or summary is included. No evidence were available after recent evidence window.

290
Elbit Systems Ltd.
lowweak
Opp 1
Risk 1

Thesis: Despite broad defense and geopolitical exposure implied by context, the reviewed sources have no direct negative evidence within the recent evidence window, so no adverse thesis is supportable.

Why now: Membership rationale references articles: and, but coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. unavailable in reviewed sources.

Caveats: Large mention volume is not conviction. Defense-space context is not directional proof. Referenced have no in the reviewed sources.

291
Element U.S. Space & Defense
lowweak
Opp 0
Risk 1

Thesis: No direct adverse evidence is retained, but the company is especially thinly covered in these reviewed sources, which raises uncertainty rather than a demonstrable risk case.

Why now: Why now is absent because only 2 articles were considered and none survived the 90-day filter; there is no current evidence basis for a 1 year+ directional call.

Caveats: Coverage is extremely sparse. The only described relation is context/service oriented and relations are context-only unless policy-gated. No post-cutoff evidence available.

292
Emposat
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is available within the reviewed sources' recent evidence window.

Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Emposat.

Caveats: Phase-2 membership rationale references articles and, but the reviewed sources provide no for citation. Ground-station context is indirect and not enough for a strong thesis under the evidence standard.

293
EnduroSat
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is provided in the reviewed sources after recent evidence filtering, so a negative thesis is unsupported.

Why now: Why now is unsupported because no evidence remain after recent evidence filtering; there is no dated catalyst, financing, contract, production, or customer evidence available here.

Caveats: No surviving evidence after recent evidence filtering. Reviewed evidence counts indicate evidence existed upstream, but none is included here for direct citation. Low scores reflect missing evidence, not a fundamental negative judgment.

294
Filtronic PLC
lowweak
Opp 2
Risk 1

Thesis: No material adverse thesis is supported because no direct negative evidence is retained in the reviewed sources.

Why now: There is no evidenced near-term or durable why-now catalyst inside the retained 90-day evidence window.

Caveats: Reviewed evidence references but provides no representative article. Potentially positive older context may be stale or superseded; recency cannot be validated. No retained evidence after recent evidence window.

295
FOSSA Systems
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is available in the reviewed sources, so there is no supported risk thesis beyond generic startup and execution uncertainty, which is insufficient under the evidence rules.

Why now: No within the recent evidence window evidence are available after filtering, so there is no near-dated trigger or state change that can be scored from the local reviewed sources.

Caveats: Membership support references article, but that article content is not available here for direct citation. Coverage debug shows zero evidence after recent evidence window. A positive thesis requires positive evidence, not just category fit or membership rationale.

296
Fujitsu
lowweak
Opp 3
Risk 1

Thesis: No material negative evidence is available. The main risk is that space may remain too small a contributor within Fujitsu's broader business to drive a distinct thesis, but this is an inference from the reviewed sources' boundary ambiguity rather than direct adverse evidence (: and; not provided in reviewed sources).

Why now: An MOU in SDA could matter over a 1 year+ horizon if it converts into deployments or service revenue, but the reviewed sources offers no direct dated evidence inside recent evidence window and no article to validate timing.

Caveats: Large diversified company; reviewed sources does not show materiality of space effort. MOU is weaker than signed commercial contract revenue evidence. No direct article content or is available in reviewed sources.

297
GE Aerospace
lowweak
Opp 1
Risk 1

Thesis: No reviewed sources-supported adverse thesis is available. There is also no material direct negative evidence after the 90-day recent evidence window.

Why now: There is no current catalyst in the reviewed sources. Coverage shows 32 article IDs considered but zero article IDs after recent evidence window and zero evidence after recent evidence window, so recency-based ranking is not supported.

Caveats: Phase2 rationale says only generic stock-screener style article context was available, citing article IDs, and, but no were provided in the reviewed sources. Evidence recent evidence review shows no current evidence was retained and undated_rows_kept = 0. Without for the cited membership-support articles, they cannot be used as factual thesis evidence under the citation requirement.

298
Gilat Satellite Networks Ltd.
lowweak
Opp 1
Risk 1

Thesis: Insufficient retained local evidence within the 90-day recent evidence window to support a material adverse thesis.

Why now: No company-specific dated evidence were retained after the 90-day recent evidence window cutoff of March 29, 2026, so there is no current catalyst basis in the reviewed sources.

Caveats: Reviewed evidence shows 64 articles considered but 0 article IDs after recent evidence window and 0 evidence retained. Membership support cited article IDs: and: but no article summaries or retained evidence are provided in these reviewed sources, so no factual thesis claims can be grounded from them.

299
GS Yuasa Corporation
lowweak
Opp 3
Risk 1

Thesis: No material adverse evidence is retained. The main limitation is that the reviewed sources does not prove the scale, growth, or competitiveness of GS Yuasa's space exposure.

Why now: There is no verified near-term catalyst, but the reviewed sources' phase-2 rationale references saying GS Yuasa was named as a key player in a space battery market report. Without, timing detail, or retained evidence, recency is uncertain.

Caveats: The rationale cites, but no or retained article text is provided. Being listed as a key player in a market report is weaker than direct contract, launch, or financial evidence. No retained evidence remain after the 90-day recent evidence window.

300
HawkEye 360, Inc.
lowweak
Opp 2
Risk 1

Thesis: Government concentration or defense-program dependence could be a risk, but the reviewed sources contain no direct negative evidence within the available recent evidence window.

Why now: There is no available post-recent evidence window evidence in the reviewed sources to establish a current catalyst or changed business state.

Caveats: No evidence available after recent evidence window. Cannot rely on membership rationale alone for direction.